Latest News

Voters don’t like ‘Big Pharma.’ But they could soon elect a Senate that includes two pharma lobbyists and a CEO

WASHINGTON — In the past year alone, President Trump has bellyached about drug makers charging “rip-off” prices, numerous Democrats have accused the pharmaceutical industry of pure greed, and polls have shown that voters believe lowering the cost of prescription medicines should be among government’s top priorities.

But if Republicans prevail in just two nailbiter races on Tuesday, the Senate’s ranks would suddenly include two former drug industry lobbyists and even a pharma CEO.

Read the rest…

Source link

Related posts

Federal proposals to block Medicaid funding would affect community health centers


For every 69 high-dose opioid prescriptions, U.S. pharmacies dispensed only one overdose-reversal drug


Global Diphtheria Ongoing Clinical Trials Analysis & Outlook to 2022 –


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy